IT Software Products company Quick Heal Technologies announced Q3FY25 results Revenue: Rs 70.6 crore for Q3FY25. EBITDA: -3.8 crore for Q3FY25. EBITDA Margin: -5.3% for Q3FY25. PAT: Rs 0.1 crore for Q3FY25. PAT margin: 0.2% for Q3FY25. Vishal Salvi, Chief Executive Officer, Quick Heal Technologies, said: “We are starting to witness successful execution of our strategic initiatives and the growing momentum in our new product pipeline. The Pan-India market launch of AntiFraud.AI, coupled with the introduction of our Annual Threat Report at the AISS event, demonstrates our thought leadership in the cybersecurity domain. Additionally, the launch of SMAP (Seqrite Malware Analysis platform) and Threat Intelligence (TI) solutions, along with the first order for TI, reflects our ability to address evolving customer needs. With the recent release of the draft DPDP provisions, we are witnessing a surge in interest as our Seqrite Data Privacy products are well-positioned to capitalize on the new regulations. Our focus on innovation and strategic hirings in mid-management positions us well for sustained growth, as we continue to deliver cutting-edge cybersecurity solutions.” Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies, said: “We have witnessed headwinds in the Consumer business and Government vertical resulting in muted performance in the quarter. We have made conscious investments in the Horizon-3 product launches and the marketing launch of AntiFraud product. I am happy to state that we have launched the new product in the Horizon-3 category as we had committed. While it might have impacted the profitability in the short term, which is Q3, these are long-term investments made towards our growth journey for the future. We are experiencing structural shift in our business, with a growing confirmed order book standing at 7.18 crore as against 35 lacs at the end of Q2. We remain committed to balancing innovation with financial prudence, ensuring long-term value creation for our stakeholders.” Result PDF